BiotechTube

atorvastatin, Lipitor

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hypercholesteremia

Conditions

Hypercholesteremia, Coronary Artery Disease

Trial Timeline

— → —

NCT ID
NCT00408382

About atorvastatin, Lipitor

atorvastatin, Lipitor is a approved stage product being developed by Astellas Pharma for Hypercholesteremia. The current trial status is completed. This product is registered under clinical trial identifier NCT00408382. Target conditions include Hypercholesteremia, Coronary Artery Disease.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00408382ApprovedCompleted

Competing Products

5 competing products in Hypercholesteremia

See all competitors
ProductCompanyStageHype Score
Rosuvastatin + HMG CoA inhibitorShionogiApproved
85
SHR-1209 + PlaceboJiangsu Hengrui MedicinePhase 1
33
Rosuvastatin calciumAstraZenecaPhase 3
77
Rosuvastatin + AtorvastatinAstraZenecaPhase 3
77
MK-0524A + ER Niacin + PlaceboMerckPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85